Investment/deal trends for emerging therapeutic companies 2008-2017

US venture capital and public offerings 2008-2017, global licensing and acquisitions 2008-2017, current pipeline for emerging companies

This report from June 2018 identifies trends affecting emerging therapeutic companies across five core areas of investment and deal-making: venture capital, initial public offerings (IPOs), follow-on public offerings (FOPOs), licensing, and acquisitions. The report uses data from the most recent 10 years and categories are broken down by phase of development and disease area.
  • Language: English
  • Released: June 2018

Please sign up for free to download this report.
More than 7,500
companies
trust
Statista
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!